Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Resistance In Eye Surgeries
NCT04750655Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2021
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of moxifloxacin in endophthalmitis, sponsored by University of California, San Francisco. Started Mar 2021; status: completed.
02
Drugs
moxifloxacin
03
Conditions
endophthalmitis
Beyond the preview
Go deeper on NCT04750655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750655.